Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Novartis |
---|---|
Information provided by: | Novartis |
ClinicalTrials.gov Identifier: | NCT00463801 |
This study will evaluate the safety and efficacy of daptomycin against complicated skin and skin-structure infections in adults
Condition | Intervention | Phase |
---|---|---|
Staphylococcal Skin Infections |
Drug: Daptomycin |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Multicentre, Open Label, Uncontrolled Clinical Trial to Evaluate Efficacy and Safety of Daptomycin for the Treatment of Complicated Skin and Skin-Structure Infections (cSSTI) Caused by Methicillin-Resistant Staphylococcus Aureus (MRSA) |
Estimated Enrollment: | 104 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Inclusion criteria:
Exclusion criteria:
Contact: novartis | 41613241111 |
Italy | |
Novartis Italy | Recruiting |
Novartis Italy, Italy | |
Contact: Novartis Basel 41 61 324 1111 | |
Novartis Italy | Recruiting |
Saronno, Italy | |
Contact: Renato Turrini 39 02 96543280 renato.turrini@pharma.novartis.com |
Study Director: | Novartis | Novartis |
Responsible Party: | Novartis ( Novartis ) |
Study ID Numbers: | CCBC134AIT01 |
Study First Received: | April 19, 2007 |
Last Updated: | October 2, 2008 |
ClinicalTrials.gov Identifier: | NCT00463801 |
Health Authority: | Italy: Agenzia Italiana del Farmaco (AIFA) |
Complicated Skin and Skin-Structure Infections, Daptomycin, MRSA, Diabetic Foot, Abscess, Cellulitis Complicated skin and skin-structure infections |
Daptomycin Bacterial Infections Staphylococcal Infections Gram-Positive Bacterial Infections Skin Diseases, Infectious Cellulitis |
Methicillin Skin Diseases Skin Diseases, Bacterial Abscess Staphylococcal Skin Infections Diabetic Foot |
Anti-Infective Agents Anti-Bacterial Agents Communicable Diseases |
Therapeutic Uses Infection Pharmacologic Actions |